<?xml version="1.0" encoding="UTF-8"?>
<p id="para0031">Arbidol is an antiviral drug against influenza infection that is widely used in Russia and China. Arbidol and arbidol mesylate were shown to have a potent inhibitory effect in reducing the reproduction of SARS-CoV in vitro 
 <xref rid="bib0080" ref-type="bibr">[80]</xref>. Low-level evidence including a retrospective cohort study, case reports and case series revealed that arbidol alone or combined with antiviral drugs produced certain benefits in the treatment of COVID-19 pneumonia 
 <xref rid="bib0081" ref-type="bibr">[81]</xref>, 
 <xref rid="bib0082" ref-type="bibr">[82]</xref>, 
 <xref rid="bib0083" ref-type="bibr">[83]</xref>. Currently, many randomised clinical controlled trials are being carried out studying the efficacy of Arbidol on COVID-19 pneumonia in China.
</p>
